In multivariable analysis, high GI/HRD score, advanced T stage and lymph node metastasis were independently associated with overall survival in the training cohort; TP53 alteration, male sex and distant metastasis were independently associated with overall survival in the validation cohort (Table 1). Here, TP53 is linked to metastatic malignant neoplasm in the lymph nodes.